# Safety and Efficacy of Autologous Bone Marrow Stem Cells for Treating Chronic Renal Failure

> **NCT01152411** · PHASE1,PHASE2 · UNKNOWN · sponsor: **International Stemcell Services Limited** · enrollment: 5 (estimated)

## Conditions studied

- Chronic Renal Failure

## Interventions

- **OTHER:** Autologous bone marrow stem cells

## Key facts

- **NCT ID:** NCT01152411
- **Lead sponsor:** International Stemcell Services Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-02
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2012-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01152411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01152411, "Safety and Efficacy of Autologous Bone Marrow Stem Cells for Treating Chronic Renal Failure". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01152411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*